Zomedica’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

Zomedica is a pharmaceutical company that develops and commercializes drug-based therapeutics for the treatment of pet chronic diseases. Read more

Robert Cohen's photo - Interim-CEO of Zomedica

Interim-CEO

Robert Cohen

CEO Approval Rating

90/100

Founded:

2013

Status:

PublicOtherZOM

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Antech is Zomedica's top competitor. Antech is a Private company that was founded in Los Angeles, California in 1994. Antech operates in the Health Care Services industry. Antech has 787 more employees vs. Zomedica.

IDEXX has been one of Zomedica's top competitors. IDEXX is headquartered in Westbrook, Maine, and was founded in 1983. IDEXX is in the Biotechnology field. IDEXX generates 51,155% the revenue of Zomedica.

Abaxis is perceived as one of Zomedica's biggest rivals. Abaxis was founded in 1989 in Union City, California. Abaxis competes in the Health Care Services field. Abaxis generates $49.7M more revenue than Zomedica.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Kindred Biosciences a competitor of Zomedica?

Quarterly and Annual Revenue

Coming soon for Zomedica!

Annual Revenue

$4.9M

Zomedica's revenue is the ranked 15th among it's top 10 competitors. The top 10 competitors average 1.1B.

Acquisitions

No recent acquisitions found related to Zomedica

Zomedica Funding History

$8.4M$11.8M$17.8M$36.8M$57.7M

Since Zomedica was founded in 2013, it has participated in 12 rounds of funding. In total Zomedica has raised $57.7M. Zomedica's last funding round was on May 2020 for a total of $20.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Private Placement
May 2020
$20M
-
Debt - PPP (CARES Act)
Apr 2020
$527.4K
Debt - PPP (CARES Act)
Apr 2020
$350K - $1M

U.S. Small Business Administration.

Private Placement
Jun 2019
$7M
-
Equity
May 2019
$12M
-

Total Funding: $57.7M

Since Zomedica was founded in 2013, it has participated in 12 rounds of funding. In total Zomedica has raised $57.7M. Zomedica's last funding round was on May 2020 for a total of $20.0M

Investments

No recent investments found related to Zomedica

Zomedica News

August 31, 2020MarketScreener

Second-Quarter 2020 Financial Results

(marketscreener.com) Management Discussion and Analysis Consolidated Financial Statements For the thr... See more »
August 10, 2020BioSpace

Zomedica Announces Second Quarter 2020 Financial Results

Zomedica Pharmaceuticals Corp. (NYSE American:ZOM) ("Zomedica" or "Company"), a veterinary health com... See more »
August 7, 2020Benzinga

Zomedica Adds Two New Directors To Board Annual Meeting Materials Availability

ANN ARBOR, Mich., Aug. 07, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. ("Zomedica") (NYSE... See more »
August 4, 2020Zacks

What's in the Cards?

Zomedica (ZOM) will provide an update on Truforma, its inaugural point-of-care diagnostic biosensor p... See more »
July 27, 2020Zacks

What You Should Know

Zomedica Pharmaceuticals Corp. (ZOM) closed at $0.16 in the latest trading session, marking a -0.3% m... See more »
July 5, 2020themarketsdaily

Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) Expected to Post Earnings of -$0.01 Per Share

Equities analysts expect that Zomedica Pharmaceuticals Corp (NYSEAMERICAN) (NYSE:ZOM) will post ($0.0... See more »
July 2, 2020Crain's Detroit Business

Zomedica launches $30 million public offering

Ann Arbor-based Zomedica Pharmaceuticals Corp. seeks to raise about $30 million in a new public offer... See more »

Zomedica Blogs

August 28, 2019Zomedica Blog

Racelle LaMar, DVM: Rising from the Ashes

As a sole practitioner with a well-established small animal practice in Santa Rosa, California, Racel... See more »
April 18, 2019Zomedica Blog

Kimberly Pope-Robinson, DVM: 1 Life Connected

At one point in her life, Kimberly Pope-Robinson, DVM, CCFP was at a crossroads. Suffering from menta... See more »
March 7, 2019Zomedica Blog

Debbie Breitstein, DVM: Desire and determination in veterinary medicine

Even as a child, Dr. Debbie Breitstein knew that she wanted to be a veterinarian. She didn’t even wav... See more »
November 15, 2017Zomedica Blog

Rebecca Rodriguez: Finding Health and Happiness as a Veterinary Technician

For Rebecca Rodriguez, her passion for veterinary medicine didn't begin at an early age. With a backg... See more »
October 11, 2017Zomedica Blog

Diane Krumanaker, DVM: The power of the positive in practice

It's hard to say what paves the road to success, but for Diane Krumanaker, DVM, the power of positive... See more »
August 16, 2017Zomedica Blog

Corey Gut, DVM: Being Brave and Staying Strong to Make a Difference for Pets and Families

Dr. Corey Gut is a veterinarian at DePorre Veterinary Hospital in Bloomfield Hills, Michigan. Her pas... See more »
April 11, 2017Zomedica Pharmaceuticals Blog

Keri Florida, DVM: A Voice for Patients Who Can't Speak for Themselves

Keri Florida, DVM, works as an associate veterinarian with the Swartz Creek Veterinary Hospital, a wa... See more »

Zomedica Press Releases

January 30, 2020centralcharts

Zomedica to Voluntarily Delist its Common Shares from TSX Venture Exchange Effective February 10, 2020

ANN ARBOR, Mich., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZO... See more »
January 23, 2020GlobeNewswire

Zomedica to Focus on TRUFORMA Commercialization

Strategic Plan to Emphasize Point-of-Care DiagnosticsStrategic Plan to Emphasize Point-of-Care Diagno... See more »
November 5, 2019GlobeNewswire

Zomedica Announces 2019 Annual Meeting Results

ANN ARBOR, Mich., Nov. 05, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (TSX-V:ZOM) ("Zome... See more »
October 31, 2019GlobeNewswire

Zomedica Commences Final TRUFORMA Diagnostic Verification Study

Expects to Commence Commercialization Activities in Q1 2020Expects to Commence Commercialization Acti... See more »
August 8, 2019GlobeNewswire

Zomedica Announces Second Quarter 2019 Financial Results

ANN ARBOR, Mich., Aug. 08, 2019 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American:ZOM... See more »

Zomedica Videos

Headquarters

100 Phoenix Drive Suite 190

Ann Arbor, Michigan48108

1-734-369-2555

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

Zomedica is a pharmaceutical company that develops and commercializes drug-based therapeutics for the treatment of pet chronic diseases. Zomedica was founded in 2013. Zomedica's headquarters is located in Ann Arbor, Michigan, USA 48108. It has raised ...

CEO

Zomedica's Interim-CEO, Robert Cohen, currently has an approval rating of 90%. Zomedica's primary competitors are Antech, IDEXX & Abaxis.

Website

zomedica.com

Frequently Asked Questions about Zomedica

  1. When was Zomedica founded?

    Zomedica was founded in 2013
  2. Who is Zomedica's CEO?

    Zomedica's CEO is Robert Cohen
  3. How much revenue does Zomedica generate?

    Zomedica generates $4.9M in revenue
  4. How much funding does Zomedica have?

    Zomedica has historically raised $57.7M in funding
  1. Where is Zomedica's headquarters?

    Zomedica's headquarters is in Ann Arbor Michigan, USA
  2. How many employees does Zomedica have?

    Zomedica has 28 employees
  3. What sector does Zomedica operate in?

    Zomedica is in Pharmaceuticals, Biotechnology
  4. Who are Zomedica's competitors?

    Zomedica's top competitors are Antech, IDEXX, Abaxis